Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity

[1]  K Suzuki,et al.  Reproducibility of [11C]FLB 457 binding in extrastriatal regions , 2001, Nuclear medicine communications.

[2]  Yoshiro Okubo,et al.  Dopamine D2 Receptors in the Insular Cortex and the Personality Trait of Novelty Seeking , 2001, NeuroImage.

[3]  V Kaasinen,et al.  Sex differences in extrastriatal dopamine d(2)-like receptors in the human brain. , 2001, The American journal of psychiatry.

[4]  J. Rinne,et al.  Role of the dopaminergic system in chronic pain – a fluorodopa-PET study , 2001, Pain.

[5]  Kjell Någren,et al.  Measurement of extrastriatal D2-like receptor binding with [11C]FLB 457 – a test-retest analysis , 2000, European Journal of Nuclear Medicine.

[6]  M. Laruelle.  Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  J. Magnusson,et al.  The involvement of dopamine in nociception: the role of D1 and D2 receptors in the dorsolateral striatum , 2000, Brain Research.

[8]  J. Stewart,et al.  The role of dopamine in the nucleus accumbens in analgesia. , 1999, Life sciences.

[9]  C. Halldin,et al.  Quantification of [11C]FLB 457 Binding to Extrastriatal Dopamine Receptors in the Human Brain , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  J. Maisog,et al.  Pain intensity processing within the human brain: a bilateral, distributed mechanism. , 1999, Journal of neurophysiology.

[11]  J. Levine,et al.  Pain-Induced Analgesia Mediated by Mesolimbic Reward Circuits , 1999, The Journal of Neuroscience.

[12]  K. Någren,et al.  Measurement of Striatal D2 Dopamine Receptor Density and Affinity with [11C]-Raclopride in Vivo: A Test-Retest Analysis , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  A. Rivera,et al.  Differential regional and cellular distribution of dopamine D2‐like receptors: An immunocytochemical study of subtype‐specific antibodies in rat and human brain , 1998, The Journal of comparative neurology.

[14]  E. Chudler,et al.  Response properties of neurons in the caudate–putamen and globus pallidus to noxious and non-noxious thermal stimulation in anesthetized rats , 1998, Brain Research.

[15]  A. Malhotra,et al.  Dopamine D2 receptor density and personal detachment in healthy subjects. , 1998, The American journal of psychiatry.

[16]  Victor W. Pike,et al.  Improved syntheses of the PET radioligands, [11C]FLB 457, [11C]MDL 100907 and [11C]β‐CIT‐FE, by the use of [11C]methyl triflate , 1998 .

[17]  K. Någren,et al.  Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo. , 1998, The American journal of psychiatry.

[18]  J O Rinne,et al.  The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers , 1998, Molecular Psychiatry.

[19]  J. Stewart,et al.  Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine. , 1998, The Journal of pharmacology and experimental therapeutics.

[20]  B. Uludaǧ,et al.  Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy , 1998, Pain.

[21]  S. Jabbur,et al.  Augmentation of nociceptive reflexes and chronic deafferentation pain by chemical lesions of either dopaminergic terminals or midbrain dopaminergic neurons , 1997, Brain Research.

[22]  J. Petter Gustavsson,et al.  D2 dopamine receptors and personality traits , 1997, Nature.

[23]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[24]  C. Halldin,et al.  Variability in D2‐dopamine receptor density and affinity: A PET study with [11C]raclopride in man , 1995, Synapse.

[25]  E. Chudler,et al.  The role of the basal ganglia in nociception and pain , 1995, Pain.

[26]  Christer Halldin,et al.  Distribution of D1- and D2-Dopamine Receptors, and Dopamine and Its Metabolites in the Human Brain , 1994, Neuropsychopharmacology.

[27]  V. Lehtinen,et al.  Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography. , 1994, Archives of general psychiatry.

[28]  J S Fowler,et al.  Striatal binding of the PET ligand 11C‐raclopride is altered by drugs that modify synaptic dopamine levels , 1993, Synapse.

[29]  L. Farde,et al.  PET analysis of central [11 C]raclopride binding in healthy young adults and schizophrenic patients—reliability and age effects , 1992 .

[30]  K. Franklin,et al.  Dopamine receptor subtypes and formalin test analgesia , 1991, Pharmacology Biochemistry and Behavior.

[31]  N. Schneiderman,et al.  Blood pressure reactivity and perception of pain during the forehead cold pressor test. , 1991, Psychophysiology.

[32]  Karl J. Friston,et al.  Cortical and subcortical localization of response to pain in man using positron emission tomography , 1991, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[33]  J. Costentin,et al.  Stimulation of dopamine D2 receptors induces an analgesia involving an opioidergic but non enkephalinergic link. , 1990, European journal of pharmacology.

[34]  T. Morrow,et al.  Cocaine: evidence for supraspinal, dopamine-mediated, non-opiate analgesia , 1989, Brain Research.

[35]  S. Fleetwood-Walker,et al.  Antinociceptive actions of descending dopaminergic tracts on cat and rat dorsal horn somatosensory neurones. , 1988, The Journal of physiology.

[36]  M. Bushnell,et al.  Diffuse noxious inhibitory controls (DNICs): psychophysical evidence in man for intersegmental suppression of noxious heat perception by cold pressor pain , 1987, Pain.

[37]  J. P. Gonzalez,et al.  Dopamine receptor‐mediated spinal antinociception in the normal and haloperidol pretreated rat: effects of sulpiride and SCH 23390 , 1987, British journal of pharmacology.

[38]  G. Schott.  Pain in Parkinson's disease , 1985, Pain.

[39]  J. Willer,et al.  Psychophysical and electrophysiological approaches to the pain-relieving effects of heterotopic nociceptive stimuli. , 1984, Brain : a journal of neurology.

[40]  W. Koller,et al.  Sensory symptoms in Parkinson's disease , 1984, Neurology.

[41]  T. Jensen,et al.  Effects of an intrathecal dopamine agonist, apomorphine, on thermal and chemical evoked noxious responses in rats , 1984, Brain Research.

[42]  J. J. Wu,et al.  Effects of kainic acid injections in the striatum on physiologic and behavioral functions in conscious rats , 1984, Experimental Neurology.

[43]  R. Melzack,et al.  Effects of cholinergic and dopaminergic agents on pain and morphine analgesia measured by three pain tests , 1983, Experimental Neurology.

[44]  L. Paalzow,et al.  Opposing effects of apomorphine on pain in rats. Evaluation of the dose-response curve. , 1983, European journal of pharmacology.

[45]  A. Pertovaara,et al.  Ischemic pain nonsegmentally produces a predominant reduction of pain and thermal sensitivity in man: A selective role for endogenous opioids , 1982, Brain Research.

[46]  Donald F. Smith,et al.  Dopaminergic effects on tail-flick response in spinal rats. , 1982, European journal of pharmacology.

[47]  S. Kernbaum,et al.  Administration of levodopa for relief of herpes zoster pain. , 1981, JAMA.

[48]  H. Akil,et al.  Monoaminergic mechanisms of stimulation-produced analgesia , 1975, Brain Research.

[49]  A. Mitra,et al.  Pulmonary biotransformation of insulin in rat and rabbit. , 1992, Life sciences.

[50]  M. Bushnell,et al.  A psychophysical comparison of sensory and affective responses to four modalities of experimental pain. , 1992, Somatosensory & motor research.

[51]  N. Dafny,et al.  D2 dopamine receptor involvement in spinal dopamine-produced antinociception. , 1992, Life sciences.

[52]  C. Tanner,et al.  Pain in Parkinson's disease , 1986, Movement disorders : official journal of the Movement Disorder Society.

[53]  R. Sewell,et al.  Differential effects of SKF 38393 and LY 141865 on nociception and morphine analgesia. , 1983, Life sciences.